VB
Vikas Bhardwaj
Medical Technologist, AIIMS New Delhi
Updated: Apr 17, 2026
**Core Concept**
Acetazolamide is a carbonic anhydrase inhibitor that increases renal excretion of bicarbonate and hydrogen ions, thereby reducing the risk of high altitude sickness. However, in the context of type 1 diabetes, acetazolamide can exacerbate metabolic acidosis by inhibiting a critical cellular reaction.
**Why the Correct Answer is Right**
In the setting of type 1 diabetes, acetazolamide inhibits carbonic anhydrase in the renal proximal tubular cells, where it normally facilitates the reabsorption of bicarbonate ions. By inhibiting this enzyme, acetazolamide reduces the reabsorption of bicarbonate, leading to its increased excretion in the urine. This results in a net loss of bicarbonate ions, contributing to the development of metabolic acidosis. Furthermore, in the context of ketoacidosis, the increased excretion of bicarbonate ions can worsen the metabolic acidosis by failing to adequately counteract the accumulation of acidic ketone bodies.
**Why Each Wrong Option is Incorrect**
* **Option A:** The renal distal tubular cells are not primarily involved in the reabsorption of bicarbonate ions, making them less relevant to the mechanism of acetazolamide-induced metabolic acidosis.
* **Option B:** The liver is not directly involved in the reabsorption of bicarbonate ions in the renal proximal tubules, and thus is not the primary site of action for acetazolamide in this context.
* **Option D:** While the pancreas is involved in the pathophysiology of type 1 diabetes, it is not directly affected by the inhibitory action of acetazolamide on carbonic anhydrase in the renal proximal tubules.
**Clinical Pearl / High-Yield Fact**
Acetazolamide can worsen metabolic acidosis in patients with type 1 diabetes by inhibiting the reabsorption of bicarbonate ions in the renal proximal tubules, highlighting the importance of careful consideration of medications in patients with complex medical conditions.
**Correct Answer:** C.